Aprogen subsidiary Aprogen Biologics lends KRW 29.1 billion to Ainsfac
Bitget2026/09/23 07:34- Aprogen Biologics set a cash loan of KRW 29.1 billion to Ainsfac, starting Sept. 28, 2026.
- Loan carries 4.6% interest. Matures Sept. 27, 2027. Amount equals 10.5% of equity.
- Funds earmarked for strategic cash deployment to improve financial structure.
- Board decision dated Sept. 23, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UK 10-Year Bonds Auction Today: May Hammer at 5.41%, Auction Yield Could Hit Highest Level Since 1999
The yield on UK 10-year government bonds has reached 5.41%, the highest level in 19 years, and the £4.25 billion auction cost is the highest since 1999.
Worse than 2008? Outside the AI bubble, the new fund supported by "The Big Short" Michael Burry targets risks in private credit.
While Wall Street is busy searching for signs of a bubble in AI stocks, a new hedge fund connected to 'Big Short' Michael Burry is turning its attention to another potentially more dangerous area—private credit.
Tesla approved to launch autonomous driving software in Croatia
Crypto prices
More
